[SCHEDULE 13G/A] Alignment Healthcare, Inc. SEC Filing

Rhea-AI Filing Summary

General Atlantic and affiliated entities disclosed a shared beneficial ownership of 43,993,323 shares of Alignment Healthcare Class A common stock, representing 22.2% of the outstanding shares as of June 30, 2025. The percentage is calculated using the company figure of 198,031,417 shares outstanding reported in the company's quarterly report.

The stake is held across multiple reporting persons including General Atlantic, L.P., several GAP Coinvestments vehicles and General Atlantic (ALN HLTH), L.P. The filing states these affiliated entities may be deemed to share voting and dispositive power over the disclosed shares due to their organizational and partner relationships.

Positive

• Disclosure of 43,993,323 shares (22.2%) beneficial ownership of Alignment Healthcare Class A common stock
• Clear identification of reporting persons and affiliated structure, including General Atlantic entities and GAP coinvestment vehicles
• Percentage calculation referenced to 198,031,417 shares outstanding, providing a concrete basis for the 22.2% figure

Negative

• None.

Insights

Financial Analyst

TL;DR: General Atlantic group holds a large 22.2% stake in ALHC across affiliated entities, a material disclosed ownership position.

The Schedule 13G/A reports 43,993,323 shares beneficially owned by General Atlantic affiliates, equal to 22.2% of Alignment Healthcare based on 198,031,417 shares outstanding. This filing clarifies that voting and dispositive power is shared among multiple General Atlantic entities, which is important for assessing shareholder composition and potential consolidated influence.

Corporate Governance Expert

TL;DR: Ownership is concentrated in interrelated General Atlantic entities with shared voting and dispositive rights defined by partner and manager relationships.

The filing identifies the specific reporting persons and explains the governance links: GA ALN holds the shares of record while GA Funds and parent/partner entities share beneficial ownership and the Partnership Committee controls certain members. The disclosure documents the chain of control and the sharing of voting/disposition authority across the General Atlantic structure.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Alignment Healthcare, Inc.

(Name of Issuer)

Class A common stock, par value $0.001 per share

(Title of Class of Securities)

01625V104

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 01625V104

1

Names of Reporting Persons

General Atlantic, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 43,993,323.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 43,993,323.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

43,993,323.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

22.2 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 01625V104

1

Names of Reporting Persons

General Atlantic Partners 95, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 43,993,323.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 43,993,323.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

43,993,323.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

22.2 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 01625V104

1

Names of Reporting Persons

GAPCO GmbH & Co. KG

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

GERMANY

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 43,993,323.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 43,993,323.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

43,993,323.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

22.2 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 01625V104

1

Names of Reporting Persons

GAP Coinvestments III, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 43,993,323.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 43,993,323.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

43,993,323.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

22.2 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 01625V104

1

Names of Reporting Persons

GAP Coinvestments IV, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 43,993,323.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 43,993,323.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

43,993,323.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

22.2 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 01625V104

1

Names of Reporting Persons

GAP Coinvestments V, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 43,993,323.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 43,993,323.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

43,993,323.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

22.2 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 01625V104

1

Names of Reporting Persons

GAP Coinvestments CDA, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 43,993,323.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 43,993,323.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

43,993,323.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

22.2 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 01625V104

1

Names of Reporting Persons

General Atlantic (SPV) GP, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 43,993,323.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 43,993,323.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

43,993,323.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

22.2 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 01625V104

1

Names of Reporting Persons

GAPCO Management GmbH

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

GERMANY

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 43,993,323.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 43,993,323.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

43,993,323.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

22.2 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

CUSIP No. 01625V104

1

Names of Reporting Persons

General Atlantic GenPar, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 43,993,323.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 43,993,323.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

43,993,323.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

22.2 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 01625V104

1

Names of Reporting Persons

General Atlantic (ALN HLTH), L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 43,993,323.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 43,993,323.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

43,993,323.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

22.2 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Alignment Healthcare, Inc.
(b)	Address of issuer's principal executive offices: 1100 W. TOWN AND COUNTRY ROAD, SUITE1600, ORANGE, CA 92868
Item 2.
(a)	Name of person filing: This Statement is being filed on behalf of each of the following persons (collectively, the "Reporting Persons"): (i) General Atlantic, L.P. ("GA LP"); (ii) General Atlantic Partners 95, L.P. ("GAP 95"); (iii) GAPCO GmbH & Co. KG ("GAPCO GmbH"); (iv) GAP Coinvestments III, LLC ("GAPCO III"); (v) GAP Coinvestments IV, LLC ("GAPCO IV"); (vi) GAP Coinvestments V, LLC ("GAPCO V"); (vii) GAP Coinvestments CDA, L.P. ("GAPCO CDA"); (viii) General Atlantic (SPV) GP, LLC ("GA SPV"); (ix) GAPCO Management GmbH ("GAPCO Management"); (x) General Atlantic GenPar, L.P. ("GA GenPar"); and (xi) General Atlantic (ALN HLTH), L.P. ("GA ALN"). GA 95, GAPCO GmbH, GAPCO III, GAPCO IV, GAPCO V, and GAPCO CDA are collectively referred to as the "GA Funds."
(b)	Address or principal business office or, if none, residence: Address or principal business office or, if none, residence: The address of GA LP, GAP 95, GAPCO III, GAPCO IV, GAPCO V, GAPCO CDA, GA SPV, GA GenPar, and GA ALN is c/o General Atlantic Service Company, L.P., 55 East 52nd Street, 33rd Floor, New York, NY 10055. The address of GAPCO GmbH and GAPCO Management is c/o General Atlantic GmbH, Luitpoldblock, Amiraplatz 3, 80333 Munchen, Germany.
(c)	Citizenship: See Row (4) of each Reporting Person's cover page.
(d)	Title of class of securities: Class A common stock, par value $0.001 per share
(e)	CUSIP No.: 01625V104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Amount beneficially owned: As of June 30, 2025, the Reporting Persons owned the following number of the Company's common stock: (i) GA LP owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock (ii) GAP 95 owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock (iii) GAPCO GmbH owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock (iv) GAPCO III owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock (v) GAPCO IV owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock (vi) GAPCO V owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock (vii) GAPCO CDA owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock (viii) GA SPV owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock (ix) GAPCO Management owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock (x) GA GenPar owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock (xi) GA ALN owned of record 43,993,323 shares of common stock or 22.2% of the issued and outstanding shares of common stock The GA Funds share beneficial ownership of the shares of common stock held by GA ALN. The general partner of GA ALN is GA SPV. The general partner of GAP 95 is GA GenPar and GA GenPar is ultimately controlled by GA LP. The general partner of GAPCO GmbH is GAPCO Management. GA LP, which is controlled by the Partnership Committee of GASC MGP, LLC (the "Partnership Committee"), is the managing member of GAPCO III, GAPCO IV and GAPCO V, the general partner of GAPCO CDA and GA GenPar, and the sole member of GA SPV. The Partnership Committee also controls the investment and voting decisions of GAPCO Management. There are five members of the Partnership Committee. By virtue of the foregoing, the Reporting Persons may be deemed to share voting power and the power to direct the disposition of the shares that each owns of record. Each of the members of the Partnership Committee disclaims ownership of the shares of common stock reported herein except to the extent that he has a pecuniary interest therein. The name, the address and the citizenship of each of the members of the Partnership Committee as of the date hereof is attached hereto as Schedule A and is hereby incorporated by reference. Amount Beneficially Owned: By virtue of the relationship described above, each of the Reporting Persons may be deemed to beneficially own 43,993,323 shares of common stock.
(b)	Percent of class: All calculations of percentage ownership herein are based on an aggregate of 198,031,417 shares of common stock reported by the Company to be outstanding, as reflected in the Company's Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission on July 30, 2025.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Each of the Reporting Persons may be deemed to have the sole power to direct the voting of the shares of common stock indicated on Row (5) of each such Reporting Person's cover page included herein.
	(ii) Shared power to vote or to direct the vote: Each of the Reporting Persons may be deemed to share the power to direct the voting of the shares of common stock indicated on Row (6) of each such Reporting Person's cover page included herein.
	(iii) Sole power to dispose or to direct the disposition of: Each of the Reporting Persons may be deemed to have the sole power to direct the dispositions of the shares of common stock indicated on Row (7) of each such Reporting Person's cover page included herein.
	(iv) Shared power to dispose or to direct the disposition of: Each of the Reporting Persons may be deemed to share the power to direct the dispositions of the shares of common stock indicated on Row (8) of each such Reporting Person's cover page included herein.
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group. See Item 2, which states the identity of the members of the group filing this Schedule 13G.
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

General Atlantic, L.P.

Signature:	/s/ Michael Gosk
Name/Title:	Michael Gosk, Managing Director
Date:	08/14/2025

General Atlantic Partners 95, L.P.

Signature:	/s/ Michael Gosk
Name/Title:	Michael Gosk, Managing Director of General Atlantic, L.P., the general partner of General Atlantic GenPar, L.P., its general partner
Date:	08/14/2025

GAPCO GmbH & Co. KG

Signature:	/s/ Michael Gosk
Name/Title:	Michael Gosk, Managing Director of GAPCO Management GmbH, its general partner
Date:	08/14/2025

GAP Coinvestments III, LLC

Signature:	/s/ Michael Gosk
Name/Title:	Michael Gosk, Managing Director of General Atlantic, L.P., its managing member
Date:	08/14/2025

GAP Coinvestments IV, LLC

Signature:	/s/ Michael Gosk
Name/Title:	Michael Gosk, Managing Director of General Atlantic, L.P., its managing member
Date:	08/14/2025

GAP Coinvestments V, LLC

Signature:	/s/ Michael Gosk
Name/Title:	Michael Gosk, Managing Director of General Atlantic, L.P., its managing member
Date:	08/14/2025

GAP Coinvestments CDA, L.P.

Signature:	/s/ Michael Gosk
Name/Title:	Michael Gosk, Managing Director of General Atlantic, L.P., its general partner
Date:	08/14/2025

General Atlantic (SPV) GP, LLC

Signature:	/s/ Michael Gosk
Name/Title:	Michael Gosk, Managing Director of General Atlantic, L.P., its sole member
Date:	08/14/2025

GAPCO Management GmbH

Signature:	/s/ Michael Gosk
Name/Title:	Michael Gosk, Managing Director
Date:	08/14/2025

General Atlantic GenPar, L.P.

Signature:	/s/ Michael Gosk
Name/Title:	Michael Gosk, Managing Director of General Atlantic, L.P., its general partner
Date:	08/14/2025

General Atlantic (ALN HLTH), L.P.

Signature:	/s/ Michael Gosk
Name/Title:	Michael Gosk, Managing Director of General Atlantic, L.P., the sole member of General Atlantic (SPV) GP, LLC, its general partner
Date:	08/14/2025

Exhibit Information

Exhibit 1 - Agreement relating to the filing of joint acquisition statements as required by Rule 13d-1(k)(1) under the Act (previously filed). https://www.sec.gov/Archives/edgar/data/1017645/000095014222000589/eh220223352_13g-alignment.htm

FAQ

How many ALHC shares does General Atlantic report beneficially owning?

The filing reports 43,993,323 shares of Alignment Healthcare Class A common stock as beneficially owned by the General Atlantic reporting persons.

What percentage of ALHC outstanding shares does this represent?

The reported position represents 22.2% of the class, based on 198,031,417 shares the company reported outstanding.

Which General Atlantic entities are listed as reporting persons on the Schedule 13G for ALHC?

Reporting persons include General Atlantic, L.P.; General Atlantic Partners 95, L.P.; GAPCO GmbH & Co. KG; GAP Coinvestments III, IV, V, CDA; General Atlantic (SPV) GP, LLC; GAPCO Management GmbH; General Atlantic GenPar, L.P.; and General Atlantic (ALN HLTH), L.P.

Does the filing indicate sole or shared voting/dispositive power over the reported shares?

The filing shows 0 shares of sole voting power and sole dispositive power, and 43,993,323 shares of shared voting power and shared dispositive power for the reporting persons.

Are the reported shares held directly or on behalf of other funds or entities?

The filing states the shares are held of record by General Atlantic (ALN HLTH), L.P. and that the GA Funds share beneficial ownership; general partner and Partnership Committee relationships are described that may cause the Reporting Persons to be deemed to share ownership and control.